drugset / Trial / NCT07413172

Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye

NCT07413172

Phase 2 Not yet recruiting 20 enrolled University of Miami
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to find out whether adding sodium hyaluronate, a moisturizing ingredient commonly found in artificial tears, makes autologous serum eye drops more effective for treating moderate-to-severe dry eye disease. Each participant will use one version of the drops in one eye and the standard version in the other eye. The goal is to see if the new combination provides better relief, comfort, and eye surface healing compared to the traditional formulation.

Timeline

Start
2026-07
Primary completion
2028-07
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Serum Tears Unknown 50 % Other
Subject Sodium Hyaluronate Other / unclassified 0.2 % Other

Indications